FDA approves Rocklatan for open-angle glaucoma, ocular hypertension
- Posted on: Mar 14 2019
- Leave a response
Aerie Pharmaceuticals’ fixed-dose combination of netarsudil and latanoprost has been cleared by the FDA.
Source: AAO
Posted in: Uncategorized